Risk of hepatitis A infection among young travelers to developing countries: The need for vaccination

Journal of Travel Medicine

Volumn 4, Issue 4, 1997, Pages 195-196

  Laurichesse, Henri ^a   Peigue Lafeuille, Hélène ^a   Gibert, Richard ^b   Fuchs, Florence ^b   Beytout, Jean ^a   Rey, Michel ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HUMAN; MALE;

EID: 0031415063     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.1997.tb00821.x     Document Type: Article

References (10)

1. Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992;10(Suppl 1):S56-58.
2. Buisson Y, Roué R, Molinié C, Laverdan C. Hepatitis A virus in the French army: epidemiology and prophylaxis. In: Buisson Y, Courssaget P, Kane M, eds. Enterically-transmitted hepatitis viruses. La Simarre, Joué-Lès-Tours (France), 1996:78-84.
3. Steffen R. Hepatitis A in travelers: the European experience. J Infect Dis 1995;171(Suppl 1):S24-28.
4. André FE, D'Hondt E, Delem A, Safary A. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine 1992;10(Suppl 1):S160-168.
5. Studer S, Joller-Jemelka HI, Steffen R, Grob PJ. Prevalence of hepatitis A antibodies in Swiss travelers. Eur J Epidemiol 1993;9:50-54.
6. Fry G, Kenny JV, Quinn M, et al. Prevalence of hepatitis A IgG in Irish international travelers. Irish Med J 1993;86: 137-138.
7. Bienzle U, Bock HL, Meister W, et al. Anti-HAV seroprevalence in German travelers and hepatitis A vaccination in immune subjects [Letter]. Lancet 1993;341:1028.
8. Larouzé B, Gaudebout C, Mercier E, et al. Infection with hepatitis A and B viruses in French volunteers working in tropical Africa. Am J Epidemiol 1987;126:31-37.
9. Van Damme P, Matheï C, Thoelens S, et al. Single dose of inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity. J Med Virol 1994;44: 435-441.
10. Van Doorslaer E, Tormans G, Van Damme P. Cost-effectiveness analysis of vaccination against hepatitis A in travellers. J Med Virol 1994;44:463-469.